---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-000036"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2022-01-04T23:59:59+00:00"
generated_at: "2026-06-27T20:56:45.021472+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biodesix raises ~$16.3M via ATM equity sale, repays $20M of term loan with SVB

## Summary
- Raised ~$16.3M from sale of 3,756,994 common shares in ATM offering on Dec 30, 2021.
- Entered Consent and Second Amendment to $30M 2021 Term Loan with Silicon Valley Bank on Dec 31, 2021.
- Repaid $20M in outstanding principal on Dec 31; $600,000 prepayment fee waived.
- Amendment consents to $4.6M milestone payment under Integrated Diagnostics APA in Jan 2022.
- Company cites improved financial flexibility to advance strategic growth objectives.

## SEC filing metadata
- accession: 0000950170-22-000036
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2022-01-04T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/0000950170-22-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/bdsx-20211230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-000036
- JSON: https://secwatch.observer/filing/0000950170-22-000036.json
- Plain text: https://secwatch.observer/filing/0000950170-22-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.